After identifying your targets of interest—through WBL services or other methods—our scientists collaborate with you to develop customized targeting solutions optimized for your project’s goals.
After identifying your targets of interest—through WBL services or other methods—our scientists collaborate with you to develop customized targeting solutions optimized for your project’s goals.
Meet with our team to explore your therapeutic area of interest, establish clear objectives, and determine the optimal approach for your desired endpoints.
Leverage our biomarker discovery services to identify genes, regions, or other genomic features critical to your project.
Utilize hybridization-based enrichment with optimized oligonucleotide probes or bioinformatic targeting to analyze specific regions of interest.
Meet with our team to explore your therapeutic area of interest, establish clear objectives, and determine the optimal approach for your desired endpoints.
WBL offers custom bioinformatic solutions to balance breadth, precision, and efficiency for genomic and methylation panels. Pairing biomarker discovery services with custom bioinformatic pipelines to target regions of interest, WBL’s approach reduces noise and redundancy, delivering high-quality results for methylation and native DNA studies at any scale.
Identifying DNA’s cell or tissue of origin through methylation analysis has significant clinical applications, but its use in diagnostics has been limited by bisulfite sequencing biases and restricted target coverage. WBL’s dMS enables precise tissue-of-origin determination by detecting complex tissue-specific methylation signatures.
DNA from Tissue 1 and Tissue 2 was sequenced with dWMS. Bioinformatic targeting of 8,457 Tissue 1-specific regions allowed accurate identification (Figure 2A, 2B).
From exploratory research to targeted analyses, Wasatch BioLabs empowers precision analysis with unbiased sequencing solutions. Leveraging proprietary technologies like dTMS, tailored workflows, and expert bioinformatics support, we deliver actionable insights to advance your research.
Harness advanced tools like dTMS to develop targeted panels, analyze complex variants, and detect epigenetic modifications with scalable workflows for clinical applications.
Enhance your data with custom bioinformatics solutions, using tailored workflows and advanced analysis to generate impactful, publication-ready insights.
Work with native-read sequencing experts with decades of experience in genomics, epigenomics, and bioinformatics to guide your project from discovery to clinical success.
